News Focus
News Focus
Post# of 257264
Next 10
Followers 13
Posts 874
Boards Moderated 0
Alias Born 03/17/2011

Re: IanFromSI post# 179689

Monday, 06/23/2014 5:57:46 PM

Monday, June 23, 2014 5:57:46 PM

Post# of 257264
RE: FMI/CGIX: Gentris

http://www.gentris.com/


I couldn't find any info on what they'd ACTUALLY DONE; or what SPECIFIC technology or capability they actually have. Before the CGIX purchase, I'd never heard of them before.

I would tend to give less value to a company with lofty objectives but no documented achievements. However that would still be an uninformed conclusion. That's why I was seeking insights here.

Their words are nice, but they're totally devoid of any reference to an actual collaboration or achievement. an example from their website:


URL in case formatting gets distorted:

http://www.gentris.com/biomarker-solutions/consulting/


Gentris has extensive expertise in implementing pharmacogenomics and biorepositories for clinical trials. Our team has implemented GLP and CLIA studies for biotech and pharma companies and has been involved in writing voluntary genomic data submissions and clinical protocols. Clients can benefit from 10 years of experience at the cutting edge of PGx testing by working with Gentris experts to plan new studies, troubleshoot assays or study designs, interpret data, etc. Clients frequently ask for guidance in the following areas:

Pharmacogenomics Implementation
Clinical Trial Design
Informed Consent Assay Development
Assay Development
Technologies for Pharmacogenomics
GLP/GCP/CLIA/ISBER regulations

Quality Systems
Regulatory Compliance
Sample Shipment
Sample Logistics
Sample Handling and Storage

Advantage of Using Gentris’ Consulting Capabilities

Expertise in developing validated pharmacogenomic assays to support all phases of clinical trials
Extensive experience with regulatory agencies in the U.S., E.U., and Japan
Seamless integration with CRO partners Recognized thought leaders with extensive domain expertise
Recognized thought leaders with extensive domain expertise
Solid history of successful engagements with top pharma and biotech companies

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today